Related Experiment Video
Updated: Dec 10, 2025
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
20.0K
Metformin and cancer immunity
Ruixia Ma1,2,3, Bin Yi1,2, Adam I Riker4
1Department of Genetics, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Acta Pharmacologica Sinica
|September 2, 2020
Summary
Metformin, a diabetes drug, shows potential as an anticancer agent by modulating the immune system. It may enhance immunotherapy effectiveness and overcome resistance in cancer patients.
Area of Science:
- Immunology and Oncology
- Pharmacology
Background:
- The immune system is crucial in cancer progression, influencing tumor growth, spread, and response to therapy.
- Cancer treatment has advanced from traditional methods to immunotherapy, showing significant clinical success.
- Metformin, a type-2 diabetes medication, has demonstrated reduced cancer risk in diabetic patients.
Purpose of the Study:
- To review the literature on metformin's impact on the host immune system and cancer immunity.
- To explore metformin's potential as an anticancer agent and its role in enhancing immunotherapy.
Main Methods:
- Comprehensive literature review of studies investigating metformin's effects on cancer and immunity.
- Analysis of metformin's mechanisms of action, including its influence on the 5' adenosine monophosphate-activated protein kinase (AMPK) pathway.
- Examination of metformin's interference with immunopathological mechanisms relevant to cancer progression.
Main Results:
- Metformin exhibits antitumor effects, partly through activation of the AMPK signaling pathway.
- Studies indicate metformin interferes with key immunopathological processes involved in malignant progression.
- Evidence suggests metformin may enhance the effectiveness of immunotherapy and overcome treatment resistance.
Conclusions:
- Metformin possesses immunomodulatory properties with potential anticancer applications.
- Further research into metformin could lead to novel combination therapies to improve cancer treatment outcomes.
- Metformin's role in enhancing immunotherapy warrants continued investigation for clinical application.
More Related Videos
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
503
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
503
01:27Tumor Immunotherapy
1.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.5K
01:19Psychoneuroimmunology: Diabetes and Cancer
337
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
337
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
02:38Mitogens and the Cell Cycle
7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
02:53Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K